Development of a new aerosol barrier mask for mitigation of spread of SARS-CoV-2 and other infectious pathogens - 21/05/21
Abstract |
The COVID-19 pandemic has caused huge impact on public health and significantly changed our lifestyle. This is due to the fast airborne oro-nasal transmission of SARS-CoV-2 from the infected individuals. The generation of liquid aerosolized particles occurs when the COVID-19 patients speak, sing, cough, sneeze, or simply breathe. We have developed a novel aerosol barrier mask (ABM) to mitigate the spread of SARS-CoV-2 and other infectious pathogens. This Aerosol Barrier Mask is designed for preventing SARS-CoV-2 transmission while transporting patients within hospital facilities. This mask can constrain aerosol and droplet particles and trap them in a biofilter, while the patient is normally breathing and administrated with medical oxygen. The system can be characterized as an oxygen delivery and mitigation mask which has no unfiltered exhaled air dispersion. The mask helps to prevent the spread of SARS-CoV-2, and potentially other infectious respiratory pathogens and protects everyone in general, especially healthcare professionals.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Aerosol Barrier Mask has the potential to protect hospital workers from aerosols generated by patients |
• | System can be characterized as an oxygen delivery and mitigation mask to be used while transporting patients. |
• | Aerosol Barrier Mask can mitigate close to a 100% of the aerosols. |
Keywords : COVID-19, SARS-CoV-2, Transmission, Mitigation, Aerosols, Droplets, Mask, Pandemic, Healthcare workers
Plan
Vol 181
Article 106381- mai 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.